Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ming-I Hsu, Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
NCT01350895
First received: May 9, 2011
Last updated: November 4, 2013
Last verified: November 2013

May 9, 2011
November 4, 2013
February 2011
April 2012   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01350895 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group
Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group

To study the clinical and biochemical characteristics women with polycystic ovary syndrome (PCOS) in different aged groups.

Polycystic ovarian syndrome (PCOS) is the most frequent endocrine disorder of reproductive age women, affecting an estimated 9-18% of all women in this age group. To diagnose of PCOS in early life is especially important because it is now thought to increase metabolic and cardiovascular risks. Investigating PCOS is crucial as it is now considered to increase metabolic and cardiovascular risk, thereby impacting the health of women to a much greater extent than previously thought. We are plan using retrospective analysis to evaluate the clinical and biochemical presentation of PCOS in different aged groups.

Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

Reproductive age women

Polycystic Ovary Syndrome
Not Provided
  • Experimental Group
  • Control Group
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
781
April 2012
April 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Reproductive age women with sufficient data

Exclusion Criteria:

  • Disorders of uterus (e.g. Asherman's Syndrome, Mullerian agenesis) and chromosomal anomalies (e.g. Turner syndrome)
  • women who had had menarche at less than 3 years of age, Day 3 FSH > 15, or who were older than 46
  • women with inadequate clinical/biochemical records
  • and women who had had ovarian cysts or ovarian tumors in ultrasonography examination
  • pregnancy women
Female
18 Years to 46 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
NCT01350895
WFH-PCOS-100002
No
Ming-I Hsu, Taipei Medical University WanFang Hospital
Taipei Medical University WanFang Hospital
Not Provided
Principal Investigator: Ming-I Hsu Taipei Medical University WanFang Hospital
Taipei Medical University WanFang Hospital
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP